Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Changes in anxiety, quality of life, and functioning following psilocybin-assisted therapy in veterans with treatment-resistant depressionJournal of Affective Disorders · 2026-11-01Safety and Mental Health Outcomes of Oregon State-Regulated Psilocybin ServicesJAMA Network Open · 2026-08-19Psilocybin asymmetrically modulates outcome-based choice and cortical processing under uncertaintybioRxiv · 2026-08-13A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10Feasibility and Tolerability of Psilocybin for Phantom Limb Pain.The journal of pain · 2026-08-07Current status and future prospects of research on psilocybin's regulation of neurotransmitters and their receptors related to the pathogenesis of tinnitus.Hearing research · 2026-08-01Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST)ClinicalTrials.gov · 2026-07-30Estimating Cardiac 5-HT2B Safety Margins for Repeated Low-Dose Psilocybin Using an Exposure-Response ModelbioRxiv · 2026-07-23Probing the Functional Magnetic Resonance Imaging Response to Psilocybin in Functional Neurological Disorder (PsiFUND)ClinicalTrials.gov · 2026-07-23A randomized, double-blind, placebo-controlled single-ascending-dose study to identify a non-hallucinogenic dose of psilocybin in healthy adultsmedRxiv · 2026-07-19Psilocybin-induced behavioral and cellular effectsJournal of Neurogenetics · 2026-07-12PSilocybin Microdose for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site Phase 3 Double-blind, Placebo-controlled, Parallel-arm Clinical TrialClinicalTrials.gov · 2026-07-10Psilocybin therapy for adult females with anorexia nervosa: pilot studyThe British Journal of Psychiatry · 2026-07-08Synthesis and Biological Evaluation of 4-Bromo-dimethyltryptamine (4-Br-DMT): A Synthetic Building Block for Future Analog Development.ACS omega · 2026-07-07The need for another tool: Australian healthcare professionals on the use of psilocybin for existential distress in people with cancerBMC Medicine · 2026-07-06Psilocybin restores behavior and 5-HT2A signaling while reducing microglial density after chronic traumatic brain injury in ratsCell Reports Medicine · 2026-07-01Are we hallucinating or can psychedelic drugs modulate the immune system to control inflammation?British journal of pharmacology · 2026-07-01DESI-MSI-Based Multi-Organ Distribution Mapping of Psilocin in ZebrafishMolecules · 2026-06-18A Double Blind, Randomized Trial Investigating the Safety, Feasibility, and Mechanisms of Psychedelics in Healthy Older Adults With Low Well-being as Moderated by Biomarkers for Preclinical Alzheimer's DiseaseClinicalTrials.gov · 2026-06-08Correction to: Preliminary Evidence of Sleep Improvements Following Psilocybin Administration, and their Involvement in Antidepressant Therapeutic ActionCurrent Psychiatry Reports · 2026-06-05Developing Methods for Observing Awe Narration in Psilocybin-Assisted TherapyHealthcare · 2026-06-05The Role of the Subjective Experience in Supporting Positive Effects Following Psilocybin: a Randomized, Controlled Clinical Trial Using Risperidone in Healthy AdultsClinicalTrials.gov · 2026-06-02Prolonged Grief Symptom Outcomes During At-Home Ketamine-Assisted Therapy: A Real-World Retrospective Analysis of 503 AdultsResearch Square · 2026-06-02Trials, trips, and tribulations: pathways for implementing psychedelic therapy in Ireland.The international journal of neuropsychopharmacology · 2026-06-02Targeting Reward Circuits: Psilocybin as a Novel Therapy for Residual AnhedoniaClinicalTrials.gov · 2026-05-27Effects of Psilocybin With Psychological Support on Anhedonia in Treatment-resistant Depression: a Randomized Controlled Pilot TrialClinicalTrials.gov · 2026-05-22Does Psilocybin Require Psychedelic Effects to Treat Depression? A 4-Week, Double-Blind, Proof-of-Concept Randomized Controlled TrialClinicalTrials.gov · 2026-05-07356. Psilocybin Therapy is Associated With Decreases in Markers of Mitochondrial Stress and Inflammation in an Open-Label Clinical Trial of Parkinson’s DiseaseBiological Psychiatry · 2026-05-01High dose of psilocybin induces acute behavioral changes without inducing conditioned place preference in Sprague-Dawley rats.Journal of psychopharmacology (Oxford, England) · 2026-05-01Psilocybin use in Puerto Rico: Patterns, motivations, and personality correlates from an online surveyJournal of Psychedelic Studies · 2026-04-15Complete biosynthesis of psychedelic tryptamines from three kingdoms in plants.Science advances · 2026-04-03Psilocybin mitigates chronic behavioral and neurobiological alterations in a rat model of recurrent intimate partner violence-related brain injury.Molecular psychiatry · 2026-04-01Psychedelic-assisted pharmacotherapy: clinical applications and regulatory considerations.Expert opinion on pharmacotherapy · 2026-04-01Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects: A Randomized, Open-Label, Cross-Over Functional Magnetic Resonance Imaging TrialClinicalTrials.gov · 2026-03-24Psilocybin retail stores in Canada: Changes in availability, commercialization, and geographic distributionCanadian Journal of Public Health · 2026-03-19Inhibition of cortico-amygdala projections underlies affective bias modification by psilocybinbioRxiv · 2026-03-04Psilocybin-assisted therapy for demoralisation in hospice patients: feasibility, safety and preliminary efficacy.BMJ supportive & palliative care · 2026-02-27Delayed psilocybin treatment after repeated mild traumatic brain injury recovers chronic behavioural deficits, reduces microglial density, and enhances hippocampal neurogenesis in ratsResearch Square · 2026-02-23Microdosing psilocybin and its effect on creativity: Lessons learned from three double-blind placebo controlled longitudinal trials.Neuropharmacology · 2026-02-15A Phase 1 Translational Study to Assess Brain Activity Using Functional Magnetic Resonance Imaging (fMRI) and to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of MLS101 (Psilocybin) in Healthy VolunteersClinicalTrials.gov · 2026-02-13Single-dose psilocybin promotes cell-type-specific changes of neurons in the orbitofrontal cortex.Neurotherapeutics: the journal of the American Society for Experimental NeuroTherapeutics · 2026-01-01A Systematic Review of the efficacy, safety, and Tolerability of Psychedelics in the Treatment of post-traumatic Stress DisorderCurrent Treatment Options in Psychiatry · 2025-12-25Investigating the Effects of a Psychedelic-augmented Mental Imagery-based Intervention for Young People With Self-harm Behaviour: an Experimental Medicine StudyClinicalTrials.gov · 2025-12-05Investigational psilocybin treatment for post-traumatic stress disorder: a qualitative study of participant experience, trauma engagement, and differences from standard treatment.EClinicalMedicine · 2025-12-01Digital Intervention for Psychedelic Preparation (DIPP): A Randomised Controlled Feasibility Trial Comparing Meditation and Music-Based Programs in Healthy Volunteers.ClinicalTrials.gov · 2025-11-26Long-term outcomes of single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - 12-month data from an open-label pilot study.Journal of affective disorders · 2025-11-15Ketamine and psilocybin for athletes: A therapeutic breakthrough or a slippery slope?Performance Enhancement & Health · 2025-11-01Efficacy of Psilocybin and Trazodone Combination in Treatment-resistant Depression: a Randomized Controlled Proof-of-concept Study (PSILOTRAZ)ClinicalTrials.gov · 2025-10-07Differential effects of psilocybin and lisuride on serotonin and dopamine neuronal activity and behavior.Progress in neuro-psychopharmacology & biological psychiatry · 2025-10-02The therapeutic potential of psilocybin beyond psychedelia through shared mechanisms with ketamine.Molecular psychiatry · 2025-10-01Measurement of Serum Cytokine Levels in Samples Collected as Part of a Clinical Trial of Psilocybin for Treatment-resistant Depression.ClinicalTrials.gov · 2025-09-10Modulation of Serotonin Pathways Using Psilocybin in Adults With and Without Autism Spectrum Disorder (ASD)ClinicalTrials.gov · 2025-07-28Exploring serotonergic psychedelics as a treatment for personality disorders.Neuropharmacology · 2025-07-01Psilocybin therapy for mood dysfunction in Parkinson's disease: an open-label pilot trial.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2025-07-01The Safety and Tolerability of COMP360 in Participants With Post-traumatic Stress DisorderClinicalTrials.gov · 2025-06-13Psilocybin and hallucinogenic mushrooms - ERRATUM.CNS spectrums · 2025-06-09The Clinical Applications of Psilocybin Therapies and Post-COVID Syndrome: A Comprehensive Narrative Review.Cureus · 2025-06-01Psilocybin for disorders of consciousness: A case-report study.Clinical neurophysiology: official journal of the International Federation of Clinical Neurophysiology · 2025-05-01Evaluating the effectiveness of psilocybin in alleviating distress among cancer patients: A systematic review.Palliative & supportive care · 2025-04-22166. Dynamic Mediodorsal Thalamus Activity Predicts and Reflects Longitudinal Treatment Outcomes in Psilocybin Therapy for Treatment-Resistant DepressionBiological Psychiatry · 2025-04-09LPS-Induced Liver Inflammation Is Inhibited by Psilocybin and Eugenol in Mice.Pharmaceuticals (Basel, Switzerland) · 2025-03-23Structural basis for psilocybin biosynthesis.Nature communications · 2025-03-22Exploring Public Sentiments of Psychedelics Versus Other Substances: A Reddit-Based Natural Language Processing StudyPsyArXiv · 2025-03-07A systematic review of participant diversity in psychedelic-assisted psychotherapy trials.Psychiatry research · 2025-03-01Correction: Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc AnalysisClinical Pharmacokinetics · 2025-03-01A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.Psychedelic medicine (New Rochelle, N.Y.) · 2025-03-01A Systematic Review of Interventions for Demoralization in Patients with Chronic Diseases.International journal of behavioral medicine · 2025-02-01Validation of the Danish Translation of the Revised Mystical Experience Questionnaire (MEQ30) and Possible Impact of Setting, Dose and Intention.Journal of psychoactive drugs · 2025-01-01Compass Psychological Support Model for COMP360 Psilocybin Treatment of Serious Mental Health Conditions.The American journal of psychiatry · 2025-01-01Healing, Harms, and Humility: Expanding the Scope of Psychedelic-Assisted Psychotherapy Research.The American journal of psychiatry · 2025-01-01Psilocybin: From Psychiatric Pariah to Perceived Panacea.The American journal of psychiatry · 2025-01-01Multidimensional Personality Changes Following Psilocybin-Assisted Therapy in Patients With Alcohol Use Disorder: Results From a Double-Blind, Placebo-Controlled Clinical Trial.The American journal of psychiatry · 2025-01-01Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc AnalysisClinical Pharmacokinetics · 2025-01-01An investigation of acute physiological and psychological moderators of psychedelic-induced personality change among healthy volunteers.Neuroscience applied · 2025-01-01Psilocybin alleviates high-glucose and high-lipid-induced skin aging in BJ5Ta fibroblasts.Biochemistry and cell biology = Biochimie et biologie cellulaire · 2025-01-01Efficacy and Safety of COMP360 Psilocybin Therapy in Anorexia Nervosa: a Proof-of-concept StudyClinicalTrials.gov · 2024-12-04Psilocybin Therapy for Clinicians With Symptoms of Depression From Frontline Care During the COVID-19 Pandemic: A Randomized Clinical Trial.JAMA network open · 2024-12-02Psilocybin and hallucinogenic mushrooms.CNS spectrums · 2024-12-01PsilOCD: Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity (A Pharmacological-Challenge Feasibility Study)ClinicalTrials.gov · 2024-11-06Therapeutic Potential of Psychedelic Compounds for Substance Use Disorders.Pharmaceuticals (Basel, Switzerland) · 2024-11-05Psilocybin alters the circulating metabolomic profile in both non-clinical and clinical modelsBrain Behavior and Immunity · 2024-11-01Preliminary Evidence of Sleep Improvements Following Psilocybin Administration, and their Involvement in Antidepressant Therapeutic Action.Current psychiatry reports · 2024-11-01Psilocybin vs Escitalopram for Major Depressive Disorder: Comparative MechanismsClinicalTrials.gov · 2024-10-24Therapeutic Potential of Psychedelic Compounds for Substance Use DisordersPreprints.org · 2024-10-17Meditating on psychedelics. A randomized placebo-controlled study of DMT and harmine in a mindfulness retreat.Journal of psychopharmacology (Oxford, England) · 2024-10-01Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial.EClinicalMedicine · 2024-10-01A virtual clinical trial of psychedelics to treat patients with disorders of consciousnessbioRxiv · 2024-08-19Content analysis of Reddit posts about coadministration of selective serotonin reuptake inhibitors and psilocybin mushrooms.Psychopharmacology · 2024-08-01Psychedelic-assisted psychotherapy: where is the psychotherapy research?Psychopharmacology · 2024-08-01Psilocybin desynchronizes the human brain.Nature · 2024-08-01Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocolWellcome Open Res · 2024-07-24Ketamine-Induced Unresponsiveness Shows a Harmonic Shift from Global to Localised Functional OrganisationbioRxiv · 2024-06-25Psilocybin as a Treatment for Anorexia Nervosa: A Pilot StudyClinicalTrials.gov · 2024-06-17Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depression.Psychological medicine · 2024-06-01A Plea for Nuance: Should People with a Family History of Bipolar Disorder Be Excluded from Clinical Trials of Psilocybin Therapy?Psychedelic medicine (New Rochelle, N.Y.) · 2024-06-01An Open-Label Investigation of the Effects of Sub-Perceptual Repeat Dosing of Psilocybin on the Behavioural and Cognitive Symptoms of Fragile X Syndrome in Adult PatientsClinicalTrials.gov · 2024-05-08Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive DisorderInternational Journal of Mental Health and Addiction · 2024-03-07Established sensitization of ethanol-induced locomotor activity is not reversed by psilocybin or the 5-HT receptor agonist TCB-2 in male DBA/2J mice.Pharmacology, biochemistry, and behavior · 2024-02-01The Impact of Psilocybin on High Glucose/Lipid-Induced Changes in INS-1 Cell Viability and Dedifferentiation.Genes · 2024-01-29The Effects of Psilocybin on Lipopolysaccharide-Induced Inflammation in THP-1 Human MacrophagesPsychoactives · 2024-01-28Psilocybin in Patients With Fibromyalgia: EEG-measured Brain Biomarkers of ActionClinicalTrials.gov · 2024-01-19Modern Psychedelic Microdosing Research on Mental Health: A Systematic Review.The primary care companion for CNS disorders · 2024-01-16Serotonin 2A Receptor (5-HTR) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants.Chemical reviews · 2024-01-10Psilocybin Promotes Cell-Type-Specific Changes in the Orbitofrontal Cortex Revealed by Single-Nucleus RNA-seqbioRxiv · 2024-01-07Psychotherapy in Psychedelic Treatment: Safe, Evidence-Based, and NecessaryAmerican Journal of Psychiatry · 2024-01-01Psilocybin vs Escitalopram for depression: 6-month follow-upNeuroscience Applied · 2024-01-01Personality change in a trial of psilocybin therapy v. escitalopram treatment for depression.Psychological medicine · 2024-01-01Misinterpretations and Omissions: A Critical Response to Goodwin and Colleagues' Commentary on Psilocybin-Assisted Therapy.The American journal of psychiatry · 2024-01-01Study protocol for "Psilocybin in patients with fibromyalgia: brain biomarkers of action".Frontiers in psychiatry · 2024-01-01Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol.Wellcome open research · 2024-01-01Psilocybin and Eugenol Reduce Inflammation in Human 3D EpiIntestinal Tissue.Life (Basel, Switzerland) · 2023-12-15A history and future of psychedelics: The case of the Canadian military.Journal of military, veteran and family health · 2023-12-01Developing a Direct Observation Measure of Therapeutic Connection in Psilocybin-Assisted Therapy: A Feasibility Study.Journal of palliative medicine · 2023-12-01An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1).Pilot and feasibility studies · 2023-10-05Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.JAMA · 2023-09-05Psilocybin desynchronizes brain networks.medRxiv: the preprint server for health sciences · 2023-08-24Anti-Inflammatory Effects of Serotonin Receptor and Transient Receptor Potential Channel Ligands in Human Small Intestinal Epithelial Cells.Current issues in molecular biology · 2023-08-15A critical evaluation of QIDS-SR-16 using data from a trial of psilocybin therapy versus escitalopram treatment for depression.Journal of psychopharmacology (Oxford, England) · 2023-07-01In vivo mapping of pharmacologically induced functional reorganization onto the human brain's neurotransmitter landscape.Science advances · 2023-06-16The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant DepressionClinicalTrials.gov · 2023-04-24Canalization and plasticity in psychopathology.Neuropharmacology · 2023-03-15The Effect of Combined Treatment of Psilocybin and Eugenol on Lipopolysaccharide-Induced Brain Inflammation in Mice.Molecules (Basel, Switzerland) · 2023-03-14SV2A Marker of Synaptogenesis in a Clinical Trial of Psilocybin for DepressionClinicalTrials.gov · 2023-01-30Psilocybin as a treatment for anorexia nervosa: 6-week and 3-month follow-up resultsNeuroscience Applied · 2023-01-01Bedside to bench: the outlook for psychedelic research.Frontiers in pharmacology · 2023-01-01From prohibited to prescribed: The rescheduling of MDMA and psilocybin in AustraliaDrug Science Policy and Law · 2022-12-31Psilocybin for alcohol use disorder: Rationale and design considerations for a randomized controlled trial.Contemporary clinical trials · 2022-12-01Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicines.Neuropharmacology · 2022-11-15Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.The New England journal of medicine · 2022-11-03An Exploratory Open-Label, Phase 1b, Ascending Dose Study to Evaluate the Effects of Oral 3-[2-(Dimethylamino)Ethyl]-1h-indol-4-yl Dihydrogen Phosphate (Psilocybin, BPL-PSILO) on Cognition in Patients With Chronic Short-Lasting Unilateral Neuralgiform Headache Attacks (SUNHA)ClinicalTrials.gov · 2022-10-12Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial.JAMA psychiatry · 2022-10-01Multicentre Study To Assess Safety And Efficacy Of Psilocybin In Patients With Treatment-Resistant Depression Following Completion Of COMP 001 And COMP 003 Trials (P-TRD LTFU)ClinicalTrials.gov · 2022-09-22Synthesis, Structural Characterization, and Pharmacological Activity of Novel Quaternary Salts of 4-Substituted Tryptamines.ACS omega · 2022-07-19Mapping Pharmacologically-induced Functional Reorganisation onto the Brain’s Neurotransmitter LandscapebioRxiv · 2022-07-13Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders.Molecules (Basel, Switzerland) · 2022-04-14Genomic Analysis of Reveals Its Nutritional Strategy and Application Potential in Bioremediation.Journal of fungi (Basel, Switzerland) · 2022-02-06Structure-based discovery of nonhallucinogenic psychedelic analogs.Science (New York, N.Y.) · 2022-01-28Psilocybin for Trauma-Related Disorders.Current topics in behavioral neurosciences · 2022-01-01A Quantitative and Qualitative Report of Psilocybin Induced Mystical-Type Experiences and Their Relation to Lasting Positive EffectsPsyArXiv · 2021-12-14Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm.The Australian and New Zealand journal of psychiatry · 2021-12-01Analysis of Five Mushroom Toxins in Blood by UPLC-HRMS.Fa yi xue za zhi · 2021-10-25Spiritual experiences in psychedelic-assisted psychotherapy: Case reports of communion with the divine, the departed, and saints in research using psilocybin for the treatment of alcohol dependence.Spirituality in Clinical Practice · 2021-09-01Migraine prevalence in visual snow with prior illicit drug use (hallucinogen persisting perception disorder) versus without.European journal of neurology · 2021-07-31A Randomised, Placebo Controlled Trial of Psilocybin in Treatment Resistant Depression: A Feasibility StudyClinicalTrials.gov · 2021-07-22A dynamic and multilocus metabolic regulation strategy using quorum-sensing-controlled bacterial small RNA.Cell reports · 2021-07-20Microdosing psychedelics and its effect on creativity: Lessons learned from three double-blind placebo controlled longitudinal trialsPsyArXiv · 2021-06-14The Therapeutic Potential of Psilocybin.Molecules (Basel, Switzerland) · 2021-05-15A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT Receptor Density in the Pig Brain.International journal of molecular sciences · 2021-01-15Narratives of the mystical among users of psychedelicsActa Sociologica · 2021-01-11Psychedelics and Psychedelic-Assisted Psychotherapy.Focus (American Psychiatric Publishing) · 2021-01-01Chemical Composition of Traditional and Analog Ayahuasca.Journal of psychoactive drugs · 2021-01-01Efficacy of Psychoactive Drugs for the Treatment of Posttraumatic Stress Disorder: A Systematic Review of MDMA, Ketamine, LSD and Psilocybin.Journal of psychoactive drugs · 2021-01-01Effects of a single dose of psilocybin on behaviour, brain 5-HT receptor occupancy and gene expression in the pig.European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology · 2021-01-01A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig BrainPreprints.org · 2020-11-30P.804A single dose of psilocybin increases synaptic density and decreases 5-HT2A receptor density in the pig brainEuropean Neuropsychopharmacology · 2020-11-01Psychedelics and Psychedelic-Assisted Psychotherapy.The American journal of psychiatry · 2020-05-01Psilocybin for depression: Considerations for clinical trial designJournal of Psychedelic Studies · 2019-09-01A Randomised, Balanced, Double-blind Two-way Crossover Design Study to Evaluate the Effects of SRC Kinase Inhibitor, Saracatinib, on Brain Activity Associated With Visual Processing in Patients With Parkinson's Disease Psychosis.ClinicalTrials.gov · 2019-08-13Horizontal gene cluster transfer increased hallucinogenic mushroom diversity.Evolution letters · 2018-04-01If you give a mouse a mushroom: Behavioral effects of hallucinogens in miceeScholarship (California Digital Library) · 2017-12-31Neuronal dynamics of the anterior cingulate cortex during working memory and serotonergic manipulationImperial College London · 2017-01-01Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin.Human brain mapping · 2015-08-01Evolution of the toxins muscarine and psilocybin in a family of mushroom-forming fungi.PloS one · 2013-01-01Detection of Psilocybin Mushroom Analogs in ChocolateThe Chemical Educator · 2009-12-01Detection of Psilocybin Mushroom Analogs in Chocolate: Incorporating Current Events into the Undergraduate Teaching LaboratoryThe Chemical Educator · 2009-01-01[Hallucinogenic fungi (psilocybe). Part II. Identification of Psilocybe semilanceata by PCR].Archiwum medycyny sadowej i kryminologii · 2007-01-01Adolescent drug use in Wales.British journal of addiction · 1992-02-01Mushrooms and madness. Hallucinogenic mushrooms and some psychopharmacological implications.Canadian journal of psychiatry. Revue canadienne de psychiatrie · 1980-11-01Severe aggression in rats induced by mescaline but not other hallucinogens.Psychopharmacology · 1979-01-01On similar linguistic structures in creative performance and psilocybin-induced experience.Confinia psychiatrica. Borderland of psychiatry. Grenzgebiete der Psychiatrie. Les Confins de la psychiatrie · 1970-01-01Botanical and Chemical Characterisation of a Forensic Mushroom Specimen of the Genus PsilocybeJournal of the Forensic Science Society · 1966-07-01The Hallucinogenic Mushrooms of Mexico and Psilocybin: a BibliographyBotanical Museum leaflets Harvard University · 1962-09-07